MoonLake Immunotherapeutics — PRER14A Filings
4 PRER14A filings on record
This page lists all PRER14A filings submitted to the SEC by MoonLake Immunotherapeutics (MLTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. MoonLake Immunotherapeutics has filed 4 PRER14A documents with the SEC since 2020. To view all SEC filings by MoonLake Immunotherapeutics, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| PRER14A | PRELIMINARY REVISED PROXY MATERIALS | 0001213900-22-006911 | Feb 11, 2022 | — |
| PRER14A | PROXY STATEMENT | 0001213900-22-005287 | Feb 3, 2022 | — |
| PRER14A | PROXY STATEMENT | 0001213900-22-002878 | Jan 21, 2022 | — |
| PRER14A | PROXY STATEMENT | 0001213900-21-065511 | Dec 16, 2021 | — |